Skip to content

Understanding Severe Infections in Critically Ill Children: A Nationwide Study from Hospitals Across India

Epidemiology and Outcomes of Sepsis in Indian Pediatric Intensive Care Units A Multicentre Point Prevalence Study - SPIN-PICU (Sepsis point-Prevalence in INdian PICUs)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087243
Enrollment
480
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Mounika Vadhi Reddy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - All pediatric patients aged more than 28 days (corrected gestational age above 44 weeks) to less than 18 completed years receiving treatment in the participating PICUs at 10 AM on each study day, AND - Having clinician suspected/diagnosed sepsis, both community- and hospital/healthcare acquired, during the 24-hour window from 10 AM the previous day to 10 AM on the study day.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Point prevalence of pediatric sepsis among children admitted to Indian PICUs on pre-defined study days.Timepoint: On pre-defined study days

Secondary

MeasureTime frame
Point prevalence of septic shock among PICU admissions.Timepoint: On pre-defined study days;Distribution of pathogens, frequency and types of antimicrobials and treatments usedTimepoint: On pre-defined study days;28-day all-cause PICU and in-hospital mortality rate among sepsis patientsTimepoint: On day-28 from study day;Median PICU and hospital length of stayTimepoint: On day-28 from study day;Change in functional status from admission to hospital discharge for survivors censored at 28 daysTimepoint: On day-28 from study day;Predictors of mortality, length of stay, and organ dysfunction in pediatric sepsisTimepoint: On day-28 from study day;- Agreement of Phoenix sepsis score with clinician-suspected/diagnosed sepsis and its discriminative ability for key clinical outcomes such as mortality, length of stay and organ dysfunctionTimepoint: On pre-defined study days and On day-28 from study day;Comparison of sepsis prevalence, treatments and outcomes across different geographic regionsTimepoint: On pre-defined study days and On day-28 from study day

Countries

India

Contacts

Public ContactDr Mounika Vadhi Reddy

All India Institute of Medical Sciences, Bibinagar

doc.mounikareddy@gmail.com9855784739

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026